Fig. 5

In vivo antitumor efficacy in U87 MG tumor-bearing mice. a The mouse tumor volume change curve over time during administration. ^**P < 0.01 vs. Normal saline, and ^&P < 0.05 vs. no enhancer. b The mouse weight change curve over time during administration. c The mouse tumor volume change curve over time after the last dose, and ^&P < 0.05 vs. no enhancer. d The mouse weight change curve over time after the last dose. e Survival rate of mice in each group. Data represent the mean ± SD (n = 6)